Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Cirrhosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Testing effectiveness (Phase 2)Study completedNCT02569710
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 161
Not applicableUnknownNCT04281303
What this trial is testing

Endoscopic Bariatric Therapy in NASH Cirrhosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Instituto de Investigación Marqués de Valdecilla 10
Testing effectiveness (Phase 2)Study completedNCT03486912
What this trial is testing

Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

Who this might be right for
Hepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Bristol-Myers Squibb 155
Large-scale testing (Phase 3)Study completedNCT03235349
What this trial is testing

Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 160
Not applicableNot Yet RecruitingNCT07450651
What this trial is testing

Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

Who this might be right for
Hepatitis B Virus Related CirrhosisPortal Hypertension Related to CirrhosisEsophagogastric Varices
Beijing Friendship Hospital 150
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Large-scale testing (Phase 3)Study completedNCT03067129
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 129
Testing effectiveness (Phase 2)Looking for participantsNCT07325526
What this trial is testing

Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

Who this might be right for
Liver Cirrhosis
Boehringer Ingelheim 30
Not applicableUnknownNCT01807013
What this trial is testing

Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.

Who this might be right for
Cirrhosis
University Hospital Erlangen 200
Large-scale testing (Phase 3)Study completedNCT02207088
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis+2 more
AbbVie 68
Not applicableUnknownNCT04615091
What this trial is testing

Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery

Who this might be right for
Advanced Chronic Liver DiseaseSurgery--Complications
Azienda Ospedaliera Universitaria Integrata Verona 250
Large-scale testing (Phase 3)Study completedNCT02219490
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 1,596
Large-scale testing (Phase 3)Study completedNCT03439254
What this trial is testing

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
Intercept Pharmaceuticals 919
Testing effectiveness (Phase 2)Ended earlyNCT04267393
What this trial is testing

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Bristol-Myers Squibb 124
Not applicableUnknownNCT06397859
What this trial is testing

Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis

Who this might be right for
Hepatitis D
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 266
Large-scale testing (Phase 3)Active Not RecruitingNCT05500222
What this trial is testing

Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Who this might be right for
NASHCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 845
Large-scale testing (Phase 3)Active Not RecruitingNCT03654053
What this trial is testing

Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis

Who this might be right for
Cirrhosis
VA Office of Research and Development 142
Testing effectiveness (Phase 2)Ended earlyNCT05161481
What this trial is testing

Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Hypertension, Portal
Boehringer Ingelheim 80
Testing effectiveness (Phase 2)Study completedNCT01640964
What this trial is testing

An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension

Who this might be right for
Compensated Cirrhosis and Portal Hypertension
Novartis Pharmaceuticals 47
Next Page
15